Accipiter Biosciences vs Trially
Which Healthcare AI tool is better in 2026?
Accipiter Biosciences
AI-designed de novo protein therapies for complex diseases
Trially
Agentic AI that enrolls clinical trials faster by converting patient matches
Side-by-side
Accipiter Biosciences is the more established option (raised $12.7M); pricing is comparable on both sides.
| Metric | Accipiter Biosciences | Trially |
|---|---|---|
| Taglinei | AI-designed de novo protein therapies for complex diseases | Agentic AI that enrolls clinical trials faster by converting patient matches |
| Foundedi | 2025 | 2022🏆 |
| HQi | Seattle, United States | Kansas City, US |
| Employeesi | — | 11-50🏆 |
| Neuron scorei | 68🏆 | 50 |
| Total fundingi | $12.7M🏆 | $4.7M |
| Latest roundi | Seed · Nov 2025 | Seed |
| Valuationi | — | — |
| Cheapest paid plani | Pricing not disclosed | Pricing not disclosed |
| Free plani | ✗ | ✓ |
| Free triali | ✗ | ✓ |
| Top tier pricei | Pricing not disclosed | Pricing not disclosed |
| Pricing summaryi | Custom | Free |
| Categoriesi |
Capability matrix
Developer-facing capabilities and access signals for Accipiter Biosciences and Trially.
| Capability | Accipiter Biosciences | Trially |
|---|---|---|
| MCP support | ✗ | ✗ |
| Public API | ✗ | ✗ |
| Webhooks | ✗ | ✗ |
| OAuth 2.0 | ✗ | ✗ |
| SDK languages | — | — |
| Free plan | ✗ | ✓ |
| Free trial | ✗ | ✓ |
| Verified | ✗ | ✗ |
| Active deal | ✗ | ✗ |
🟢 Strengths of Accipiter Biosciences
- Has raised more capital ($12.7M vs $4.7M)
- Higher Neuron score (68 vs 50)
- Newer company (2025)
🔵 Strengths of Trially
- Offers a free plan
- Offers a free trial
- More mature (2022)
Which should you choose?
Choose Trially if price matters most — it starts at Free, which is friendlier for teams watching burn. Both AI Healthcare tools ship core features, so the cost delta often decides it for small teams and solo operators.
Choose Accipiter Biosciences if you want the most established option — it has raised $12.7M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.
Frequently asked questions
Accipiter Biosciences vs Trially — which is better?
It depends on your priority. Accipiter Biosciences has raised more capital and is the more established option; Trially has broader feature depth. See the side-by-side table above.
Is Accipiter Biosciences cheaper than Trially?
No — Trially's cheapest paid plan is Free, while Accipiter Biosciences's is Custom.
Do Accipiter Biosciences and Trially offer free plans?
Accipiter Biosciences: Paid only. Trially: Yes, has a free plan.
Explore more AI Healthcare tools
Contextual paths to related AI startups, deals and rankings.